Staff Members - Benha University
Micropulse transscleral diode laser cyclophotocoagulation as a treatment modality for glaucoma patients
• 2022
Publication Information
Authors
Gehad H.A. Youssefa
, Amr I. Sharawya
, Ahmed M. Saeeda
,
Mohamed A. Elsayeda
, Ahmed A.M. Abdel Latifb
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Aim
To evaluate how micropulse transscleral diode laser cyclophotocoagulation (MPTSCPC) is a safe and effective procedure, in reducing intraocular pressure (IOP) in
different glaucoma patients among the Egyptian population.
Study design
Prospective, noncomparative interventional study.
Patients and methods
This study assessed the effect of MP-TSCPC laser on patients with different types
of glaucoma. Forty eyes of 40 patients were included in our study. Patients were
recruited from Benha University Hospital and Egyptian Eye Academy, and the
procedure was done during the period between January 2020 and July 2021.
Results
The mean±SD baseline IOP was 27.72±8.6 mmHg, which showed significant
reduction at postsurgical month 6, becoming 16.28±6.38 mmHg (P=0.001). The
mean number of IOP-lowering agents was 2.35±1.03 preoperatively, which
dropped significantly to 1.50±1.24 at 6 months. Postoperative logMAR bestcorrected visual acuity was not significantly reduced from baseline. There was
no development of significant postoperative complications.
Conclusion
MP-TSCPC is an efficient, safe, and simple technique with promising results in
lowering IOP and can be used in patients with different types of glaucoma.
To evaluate how micropulse transscleral diode laser cyclophotocoagulation (MPTSCPC) is a safe and effective procedure, in reducing intraocular pressure (IOP) in
different glaucoma patients among the Egyptian population.
Study design
Prospective, noncomparative interventional study.
Patients and methods
This study assessed the effect of MP-TSCPC laser on patients with different types
of glaucoma. Forty eyes of 40 patients were included in our study. Patients were
recruited from Benha University Hospital and Egyptian Eye Academy, and the
procedure was done during the period between January 2020 and July 2021.
Results
The mean±SD baseline IOP was 27.72±8.6 mmHg, which showed significant
reduction at postsurgical month 6, becoming 16.28±6.38 mmHg (P=0.001). The
mean number of IOP-lowering agents was 2.35±1.03 preoperatively, which
dropped significantly to 1.50±1.24 at 6 months. Postoperative logMAR bestcorrected visual acuity was not significantly reduced from baseline. There was
no development of significant postoperative complications.
Conclusion
MP-TSCPC is an efficient, safe, and simple technique with promising results in
lowering IOP and can be used in patients with different types of glaucoma.